3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
67
Prostatic Neoplasms
49
Multiple Myeloma
29
Neoplasm Metastasis
27
Osteoporosis
16
Pain
15
Carcinoma, Non-Small-Cell Lung
10
Neoplasms
9
Lung Neoplasms
8
Osteosarcoma
7
Neoplasms, Plasma Cell
7
Neuroblastoma
6
Carcinoma, Renal Cell
6
Bone Diseases, Metabolic
6
Humoral Hypercalcemia Of Malignancy
5
Bone Neoplasms
5
Fractures, Bone
4
Bone Diseases
4
Sarcoma, Ewing
3
Sarcoma
3
Lymphoma
3
Kidney Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Ovarian Neoplasms
2
Interventions
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metastatic Breast Cancer With Bone Involvement
×
Zoledronic Acid
×
Clear all
NCT01344967
2015-06-23
SuBDuE
University Health Network, Toronto
Phase 2/3
Completed
21 enrolled